MYP_001734
Pegademase
Anticancer
Immunology
▸
Immune modulation
▸
Immunomodulatory activity
Therapeutic / Biomedical activity
▸
Enzyme replacement therapy
Standard
363 amino acids
C1826H2843N485O553S15
Standard
MAQTPAFNKPKVELHVHLDGAIKPETILYYGRKRGIALPADTPEELQNIIGMDKPLSLPEFLAKFDYYMPAIAGCREAVKRIAYEFVEMKAKDGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVSLVNQGLQEGERDFGVKVRSILCCMRHQPSWSSEVVELCKKYREQTVVAIDLAGDETIEGSSLFPGHVKAYAEAVKSGVHRTVHAGEVGSANVVKEAVDTLKTERLGHGYHTLEDATLYNRLRQENMHFEVCPWSSYLTGAWKPDTEHPVVRFKNDQVNYSLNTDDPLIFKSTLDTDYQMTKNEMGFTEEEFKRLNINAAKSSFLPEDEKKELLDLLYKAYGMPSPASAEQCL
40919.00 Da
5.33
-13.52
-14.52
-0.0372
-0.42
0.66
-0.02
40.76
81.10
0.0882
45840.00
46215.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0130715
VERIFIED: NO
Provenance & Taxonomy
Bos taurus [Animal]
Growth factor
9913
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
PEGylation
Bio-Activity Profile
Enzyme replacement
plasma adenosine deaminase elimination half-life is 3 to >6 days
RECORD: Rec_0289808
VERIFIED: NO
Provenance & Taxonomy
Bos taurus [Animal]
Growth factor
9913
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
PEGylation
Bio-Activity Profile
Anticancer
Immunomodulatory
Enzyme replacement
plasma adenosine deaminase elimination half-life is 3 to >6 days